Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DPI-3290 is a specific agonist of opioid receptors (Ki: 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively) with potent antinociceptive activity. DPI-3290 is one of a series of novel centrally acting agents.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 452,500 |
50 mg | 約8-10 週間 | ¥ 592,500 |
100 mg | 約8-10 週間 | ¥ 780,500 |
説明 | DPI-3290 is a specific agonist of opioid receptors (Ki: 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively) with potent antinociceptive activity. DPI-3290 is one of a series of novel centrally acting agents. |
ターゲット&IC50 | κ opioid receptor:0.62 nM, δ opioid receptor:0.18 nM, μ opioid receptor:0.46 nM |
別名 | Org 41793 |
分子量 | 487.61 |
分子式 | C30H34FN3O2 |
CAS No. | 182417-73-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DPI-3290 182417-73-8 Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor DPI3290 Org 41793 DPI 3290 Inhibitor inhibitor inhibit